Smart MDI SystemSimplera™ Continuous Glucose Monitoring and InPen™ Smart insulin pen
What is a Smart MDI system?
The Smart MDI system combines the technology of our latest innovation in continuous glucose monitoring (CGM), Simplera™ CGM with the InPen™ Smart Insulin Pen. This powerful combination is designed to take the guesswork out of multiple daily
The InPen™ smart insulin pen is designed for people with Type 1 Diabetes to track insulin doses. It provides valuable dosing recommendations and missed dose alerts.
Simplera™ CGM helps you to know before you go low or high with real- time glucose readings, trends and alerts without
The only MDI solution with dosing recommendations based on your real-time glucose and insulin levels.
Insulin management that does the thinking for you, by significantly reducing the need to check your glucose
By tracking both insulin and glucose data, it delivers personalised, real-time dosing guidance so you can take the exact dose you need. This makes it easier to manage stress, meals, exercise, and daily life.
Know before you go low or high with real-time blood glucose readings, trends and alerts.
Help prevent highs, alerting if you are trending high.
Help prevent lows, alerting if you are at low, or trending low.
Frequently asked questions
The Smart MDI System brings together an ecosystem of smart tools that provide real-time insights and comprehensive reports to make it easier to manage life on MDI.
- Simplera™ CGM is a real-time, glucose monitoring system indicated for the management of diabetes in persons aged 2 years and older.
- The InPen™ smart insulin pen is intended for single-patient use by people with diabetes for the self-injection of a desired dose of insulin. For patients who do not self-manage their diabetes, the use of InPen™ connected insulin pen should always be under the supervision of a caregiver.
We’ve updated our standalone CGM system app and hardware to improve the customer experience. These are the most significant updates that can be found in the Simplera™ CGM:
- The previous system was called the Guardian™ 4
Smart CGM System. This next generation of our Smart CGM is called the Simplera™ CGM. - The Simplera™ continuous glucose monitoring now takes just 9 seconds to insert with a two-step one-handed sensor insertion.
- No overtape required to keep sensor in place.
At this time, InPen™ smart insulin pen is compatible with Lilly Humalog®, Lilly Lyumjev®, Novo Nordisk NovoRapid®, Novo Nordisk Fiasp® and Novo Nordisk Insulin Aspart Injection, 3mL cartridges (300 units). The Smart MDI system is designed to work with standard insulin pen needles.
Colour availability varies by region. At this time, within Europe, the following colours are available:
- Blue InPen™ compatible with Novo Nordisk insulin cartridges
- Grey InPen™ compatible with Lilly insulin cartridges
The Simplera™ CGM and InPen™ connected insulin pen apps have a wide range of compatibility with several Apple® and Android™ devices. You can find updated compatibility information here on our website. We recommend checking compatibility and switching off automatic operating system updates to ensure the best possible user experience.
InPen™ connected insulin pen is the first
As part of our Smart MDI system, you can view CGM data in real time from your Simplera™ CGM by linking the app to your CareLink™ Personal account. At this time within Europe, CGM data from the Simplera™ CGM, Guardian™ Connect and Guardian™ 4 system can be viewed in the InPen™ app.
Your Healthcare Professional or Medtronic representative may provide training on the Smart MDI system. Additional resources can be found at the Medtronic Diabetes Learning Hub.
Yes, multiple InPen™ Smart insulin pens can be synced with one app account.
Cartridges are not included with InPen™ smart insulin pen. Your Healthcare Professional will provide you with your prescription for your diabetes management supplies.
Medtronic are looking to provide comprehensive self-funding options for those living with diabetes. We anticipate we will be in a position to make self-funding options available in 2024.
- * Dosing recommendation calculated as per HCP initial settings and users estimated carbohydrates amount
- ** MDI = Multiple Daily Injections
- ǁ If CGM readings do not match SG or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide
- ^ Thanks to glucose alerts and dosing recommendation calculated as per HCP initial settings
- ^^ Smart insulin pen connects to a mobile app to provide dosing calculations, reminders and CGM system integration. Please refer to IFU.
- § Some interaction required
- * Dosing recommendation calculated as per HCP initial settings and users estimated carbohydrates amount
- ** MDI = Multiple Daily Injections
- ǁ If CGM readings do not match SG or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide
- ^ Thanks to glucose alerts and dosing recommendation calculated as per HCP initial settings
- ^^ Smart insulin pen connects to a mobile app to provide dosing calculations, reminders and CGM system integration. Please refer to IFU.
- § Some interaction required
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, potential adverse events and any further information with your health care professional.
EMEA-CGM-2300085 ©2023 Medtronic. All rights reserved Medtronic. Medtronic logo and Further Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.